Skip to NavigationSkip to content

Scholar Rock prise Regulatory Affairs director away from Biogen

Published on: 18/09/17

Scholar Rock has announced that it has moved to appoint Heather Faulds as Vice President of Regulatory Affairs. Faulds joins Scholar Rock, a company currently focused on SRK-015, its lead candidate for Spinal Muscular Atrophy (SMA), from Biogen and her former position of Senior Director of Regulatory Affairs.

During her time at Biogen, Faulds was responsible for aiding in the expedited FDA approval of Spinraza, the first approved treatment for SMA, and, presumably, a big part of the reason Faulds was brought into the fold at Scholar Rock. Faulds will be tasked with managing the regulatory strategy for the company’s pipeline of drug candidates.

Faulds has 15 years of experience working in a regulatory capacity, including a number of years working through roles at Biogen – including, Senior Manager of Regulatory Affairs through to her former role as Senior Director within the same area.

“I am excited about Scholar Rock’s passionate team and inspiring vision for developing innovative medicines in areas of high unmet medical need,” said Faulds. “It was a privilege for me to contribute to the approval of the first drug product that has made such a meaningful difference in the lives of patients with SMA, and I look forward to building on that experience with the team at Scholar Rock to continue to bring SMA patients new therapeutic options.”

“I am delighted to welcome Heather to our team at this pivotal moment for Scholar Rock, as we plan and implement our regulatory strategy to advance SRK-015 into the clinic to address unmet needs for SMA patients,” said Nagesh Mahanthappa, President and Chief Executive Officer of Scholar Rock. “She brings key expertise, with a wide range of experience in regulatory affairs across all stages of development, from first-in-human studies to product approvals and product label expansions.”

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches